Pfizer up 4% as Nexium 24HR battles in the US

29 October 2014 - Deborah Wilkes

Archived

Pfizer reported a 4% rise in worldwide Consumer Healthcare sales in the third quarter of 2014, following the launch of Nexium 24HR in the US and growth of its vitamin products in emerging markets.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: